BioFocus signs compound management agreement with eMolecules, Inc.

12-Oct-2010 - United Kingdom

BioFocus and eMolecules, Inc. announced that they have signed a compound management service agreement. Under the agreement eMolecules has selected Compound Focus, Inc., the BioFocus compound management operation located in South San Francisco, as its preferred partner for client compound order aggregation services.

Clients that order compounds from multiple vendors through the eMolecules platform will have the option to ship their compounds directly from the vendor to the Compound Focus facility where both liquid and solid samples will be reformatted into preferred storage containers, passed through analytical quality control and shipped to an agreed client destination.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances